The synthesis of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, represents a complex multi-step organic process. Preliminary routes focused on protein section coupling, utilizing solid-phase production methodologies to build the long peptide sequence. Subsequent study has explored various approaches, including enzymatic